November 19, 2007
Prospector
Profile
1112-06
 
Advanced Medical Institute, Inc. NAICS 621410
Level 1, 204-218 Botany Road Alexandria, New South Wales, Australia 2015 Description Fertility Clinics
(61) 2-9640-5253 Employees 312
http://www.amiaustralia.com.au/ Revenue (mil) 39.4210
  Income (mil) -1.3200
  Assets (mil) 43.9230
  Liability (mil) 15.2450
  (for the year ended 2007-06-30)
 
Category: Loss/Deficit
 
Event: Advanced Medical Institute, Inc. had a net loss of $1,320,522 on revenues of $39,421,875 for the year ended June 30, 2007, compared to a net income of $2,465,194 on revenues of $30,453,128 reported during the previous fiscal year.
 
Intellectual Property: In 2003, the Company's Intelligent Medical Technologies Pty Limited subsidiary was granted the exclusive worldwide right and license from Sheiman Ultrasonic Research Foundation Pty Limited to exploit and sub-license certain inventions, patents and other intellectual property in relation to certain ultrasonic nebulizer technology within the field of the treatment of sexual dysfunction in men and women. The license was a broad based license which included the right to manufacture, market, sell and distribute products based on the technology and patents within the field of use. The Company applied for four worldwide patents relating to its ultrasonic nebulizer device in July 2005 and applied for three further worldwide patents relating to its device on February 10, 2006. [SEC Filing 10-KSB 10-15-07]
 
Description: The Company sells services related to the medical treatment of sexual dysfunction in Australia, New Zealand and Asia. It also provides prostate treatments to patients.
 
Officers: Jacov (Jack) Vaisman (Pres., CEO & Dir.); Dilip Shrestha (CFO); Forhad (Tony) Khan (EVP, Sec. & Dir.); Anatoly Fanshil (Dir.); Spiro Baramilis (Dir.)
 
Auditor: Kabani & Company, Inc.
 
Securities: 53,507,450 common shares outstanding as of June 30, 2007.
 
 
 
return to main page